Company / SG&A per Share
AGIOS PHARMACEUTICALS, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.15
FY2025
5-year range
$2.01 / $3.15
FY2021-FY2025
Trend
+12.5%
vs FY2024
Sector context
#59 of 210
Health Care
What the data says
At $3.15, AGIOS PHARMACEUTICALS, INC.'s sg&a per share ranks #152 of 210 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $1.67 in FY2020 to $3.15 in FY2025.
Based on SEC 10-K filings.
3.15 in FY2025 with a 5-year CAGR of +13.6%.
Increased from $2.18 to $3.15 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +14.2%
- 5-Year CAGR
- +13.6%
- 10-Year CAGR
- -
Sector benchmark
#152 of 210 in Health CareTop 72% of 210This company $3.15 Sector average $29.50
▼
-89.3% below sector average
Key checks
Key Insights
- AGIOS PHARMACEUTICALS, INC.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 12.5% year-over-year.
- Ranks #59 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.15 | +12.5% |
| FY2024 | $2.80 | +28.6% |
| FY2023 | $2.18 | +2.8% |
| FY2022 | $2.12 | +5.4% |
| FY2021 | $2.01 | +20.4% |
| FY2020 | $1.67 | -4.8% |
| FY2019 | $1.75 | +68.7% |
| FY2018 | $1.04 | -38.3% |
| FY2017 | $1.68 | +25.2% |
| FY2016 | $1.35 | +402.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026